Personal information

No personal information available

Activities

Collapse all

Employment (2)

Nereid Therapeutics: BOSTON, MA, US

2022-04-24 to present | Scientist I (Oncology)
Employment
Source: Self-asserted source
Nehal Gupta

University of California San Francisco: San Francisco, CA, US

2019-08-14 to present | Postdoctoral Researcher (Medicine)
Employment
Source: Self-asserted source
Nehal Gupta

Education and qualifications (1)

Texas Tech university health sciences center: Amarillo , Texas, US

2014-08-10 to 2019-05-12 | PhD (Pharmaceutical Sciences)
Education
Source: Self-asserted source
Nehal Gupta

Works (11)

Capicua suppresses YAP1 to limit tumorigenesis and maintain drug sensitivity in human cancer.

Cell reports
2022-10-01 | Journal article
DOI: 10.1016/j.celrep.2022.111443
PMID: 36198276
Contributors: Nehal Gupta; Kim JW; Cuyler Luck; Wu W; Ponce RK; Lin YK; Gupta N; Okimoto RA
Source: Self-asserted source
Nehal Gupta

Free Radicals as a Double-Edged Sword: The Cancer Preventive and Therapeutic Roles of Curcumin

Molecules
2020-11 | Journal article | Author
DOI: 10.3390/molecules25225390
Contributors: Nehal Gupta; Kshitij Verma; Sarath Nalla; Alok Kulshreshtha; Rajiv Lall; Sahdeo Prasad
Source: check_circle
Multidisciplinary Digital Publishing Institute

Low Dose of Penfluridol Inhibits VEGF-Induced Angiogenesis

International Journal of Molecular Sciences
2020-01 | Journal article | Author
DOI: 10.3390/ijms21030755
Contributors: Suyash Srivastava; Fatema Tuz Zahra; Nehal Gupta; Paul E. Tullar; Sanjay K. Srivastava; Constantinos Mikelis
Source: check_circle
Multidisciplinary Digital Publishing Institute

Role of Phytochemicals in Cancer Prevention.

International journal of molecular sciences
2019-10-09 | Journal article
DOI: 10.3390/ijms20204981
PMID: 31600949
PMC: PMC6834187
Source: Self-asserted source
Nehal Gupta

Atovaquone: An Antiprotozoal Drug Suppresses Primary and Resistant Breast Tumor Growth by Inhibiting HER2/β-Catenin Signaling.

Molecular cancer therapeutics
2019-07-03 | Journal article
DOI: 10.1158/1535-7163.mct-18-1286
PMID: 31270151
PMC: PMC6905100
Source: Self-asserted source
Nehal Gupta

Penfluridol overcomes paclitaxel resistance in metastatic breast cancer.

Scientific reports
2019-03-25 | Journal article
DOI: 10.1038/s41598-019-41632-0
PMID: 30911062
PMC: PMC6434141
Source: Self-asserted source
Nehal Gupta

Cancer cells stemness: A doorstep to targeted therapy.

Biochimica et biophysica acta. Molecular basis of disease
2019-02-26 | Journal article
DOI: 10.1016/j.bbadis.2019.02.019
PMID: 30818002
Source: Self-asserted source
Nehal Gupta

HER2-mediated GLI2 stabilization promotes anoikis resistance and metastasis of breast cancer cells.

Cancer letters
2018-10-26 | Journal article
DOI: 10.1016/j.canlet.2018.10.021
PMID: 30409762
PMC: PMC6311434
Source: Self-asserted source
Nehal Gupta

AKR1C3 Inhibitor KV-37 Exhibits Antineoplastic Effects and Potentiates Enzalutamide in Combination Therapy in Prostate Adenocarcinoma Cells.

Molecular cancer therapeutics
2018-06-11 | Journal article
DOI: 10.1158/1535-7163.mct-17-1023
PMID: 29891491
Source: Self-asserted source
Nehal Gupta

Role of Forkhead Box Class O proteins in cancer progression and metastasis.

Seminars in cancer biology
2017-08-01 | Journal article
DOI: 10.1016/j.semcancer.2017.07.007
PMID: 28774834
PMC: PMC5794649
Source: Self-asserted source
Nehal Gupta

Selective AKR1C3 Inhibitors Potentiate Chemotherapeutic Activity in Multiple Acute Myeloid Leukemia (AML) Cell Lines.

ACS medicinal chemistry letters
2016-06-22 | Journal article
DOI: 10.1021/acsmedchemlett.6b00163
PMID: 27563402
PMC: PMC4983729
Source: Self-asserted source
Nehal Gupta

Peer review (6 reviews for 4 publications/grants)

Review activity for Advanced science. (1)
Review activity for Cancers. (2)
Review activity for Journal of personalized medicine. (1)
Review activity for Pharmaceutical research. (2)
How many people are using ORCID?